MARKET

CMPS

CMPS

Compass Pathways Plc
NASDAQ
13.58
+1.00
+7.95%
Pre Market: 13.42 -0.16 -1.18% 08:01 06/26 EDT
OPEN
12.70
PREV CLOSE
12.58
HIGH
13.63
LOW
12.70
VOLUME
1.47K
TURNOVER
0
52 WEEK HIGH
14.76
52 WEEK LOW
2.250
MARKET CAP
1.83B
P/E (TTM)
-6.7751
1D
5D
1M
3M
1Y
5Y
1D
COMPASS Pathways (CMPS) Receives a Buy from H.C. Wainwright
TipRanks · 23h ago
3 Companies Redefining Healthcare Innovation
Seeking Alpha · 1d ago
COMPASS Pathways PLC put volume heavy and directionally bearish
TipRanks · 1d ago
Weekly Report: what happened at CMPS last week (0615-0619)?
Weekly Report · 4d ago
Unusually active option classes on open June 16th
TipRanks · 06/16 13:40
COMP360’s Phase 3 Success and FDA Filing Could Be A Game Changer For COMPASS Pathways (CMPS)
Simply Wall St · 06/15 19:12
Weekly Report: what happened at CMPS last week (0608-0612)?
Weekly Report · 06/15 09:15
Compass Pathways (CMPS) Stock After Phase 3 Success And Rolling FDA Filing How Does The Valuation Stack Up
Simply Wall St · 06/12 14:40
More
About CMPS
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.

Webull offers Compass Pathways PLC (ADR) stock information, including NASDAQ: CMPS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CMPS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CMPS stock methods without spending real money on the virtual paper trading platform.